title: EDQM biological reference preparation for rabies vaccine (inactivated) for veterinary use.
abstract: Rabies is a deadly zoonotic disease. Control of rabies in animals by vaccination is an important strategy to protect humans from infection and control the spread of the disease. Requirements for the quality control of rabies vaccines (inactivated) for veterinary use include an in vivo quantitative potency determination as outlined in the Ph. Eur. monograph 0451. Performance of this assay requires a reference preparation calibrated in International Units (IU). A European Pharmacopeia (Ph. Eur.) Biological Reference Preparation (BRP) for rabies vaccines (inactivated) for veterinary use, calibrated in IU, has been established for this purpose. Due to the dwindling stocks of the current batch (batch 4) of Ph. Eur. BRP for rabies vaccines (inactivated) for veterinary use, a collaborative study was run as part of the EDQM Biological Standardisation Programme to establish BRP batch 5. Ten laboratories, including Official Medicines Control Laboratories and manufacturers, participated. The candidate BRP5 was assayed against the 6(th) International Standard for rabies vaccine using the in vivo vaccination-challenge assay (monograph 0451) to assign a potency value. The candidate was also compared to BRP batch 4 to establish continuity. Taking into account the results from the comparisons a potency of 10 IU/vial was assigned and in March 2015 the Ph. Eur. Commission adopted the material as Ph. Eur. BRP for rabies vaccines (inactivated) for veterinary use batch 5. In addition to the in vivo assay 3 laboratories tested the candidate material using their in-house in vitro assays for information.
authors.affiliation: European Directorate for the Quality of Medicines & HealthCare (EDQM), Department of Biological Standardisation, OMCL Network & HealthCare (DBO), Council of Europe, Strasbourg, France.
authors.forename: A
authors.initials: A
authors.lastname: Daas
authors.affiliation: Institute of Virology and Immunology, Switzerland (IVI), Sensemattstrasse 293, CH 3147 Mittelhäusern, Switzerland.
authors.forename: L
authors.initials: L
authors.lastname: Bruckner
authors.affiliation: European Directorate for the Quality of Medicines & HealthCare (EDQM), Department of Biological Standardisation, OMCL Network & HealthCare (DBO), Council of Europe, Strasbourg, France.
authors.forename: C
authors.initials: C
authors.lastname: Milne
mesh_terms: D000818:Animals; D005060:Europe; D011818:Rabies / Q000188:drug therapy*; D011819:Rabies Vaccines / Q000592:standards* / Q000627:therapeutic use*; D012015:Reference Standards; D019155:Veterinary Drugs / Q000592:standards* / Q000627:therapeutic use*; D014730:Veterinary Medicine / Q000592:standards
chemical_list: D011819:Rabies Vaccines; D019155:Veterinary Drugs
keywords: Biological Reference Preparation; European Pharmacopoeia; collaborative study; in vitro assay; in vivo assay; rabies vaccine (inactivated) for veterinary use